CMS advises Alliance Pharma plc on new financing

International law firm CMS has advised Alliance Pharma plc on its new £165,000,000 revolving credit facility and a £50,000,000 accordion facility, with the transaction completing on 2 July 2019. The financing will provide Alliance Pharma plc further flexibility to deliver carefully targeted acquisitions over the next few years.

Alliance Pharma plc is an international pharmaceutical company listed on AIM, with strong expertise in the acquisition and licencing of healthcare and pharmaceutical products.

Chris Chrysanthou, Head of Legal at Alliance Pharma plc, said “Once again the Team at CMS provided sensible, commercial and practical advice in order to ensure that we were able to finalise our re-financing with the minimal fuss and maximum benefit. Ruth and her Team were, as always, a pleasure to work with”.

The cross jurisdictional team was led by Ruth Marken in London, with support from Marion Carpanen, Charlotte Choules and Gregor Hunter (Banking), Graham Chase (Tax), Paolo Bonolis and MariaGiovanna Pisani (CMS Italy) and Benoit Fournier and Benjamin Guilleminot (CMS France).